Table 2.
Baseline characteristics for patients stratified by age and CFS score category
|
CFS score 1–3 (fit) |
CFS score 4–5 (mildly frail) |
CFS score 6–9 (frail) |
|||||
|---|---|---|---|---|---|---|---|
| Age <65 years (n=792) | Age ≥65 years (n=585) | Age <65 years (n=179) | Age ≥65 years (n=385) | Age <65 years (n=125) | Age ≥65 years (n=368) | ||
| Age, years | 53 (44–60) | 74 (69–79) | 54 (45–59) | 78 (73–84) | 56 (49–60) | 79 (73–86) | |
| Sex | |||||||
| Male | 491 (62%) | 362 (62%) | 121 (68%) | 208 (54%) | 88 (70%) | 210 (57%) | |
| Female | 301 (38%) | 223 (38%) | 58 (32%) | 177 (46%) | 37 (30%) | 158 (43%) | |
| Concomitant drugs | |||||||
| Blood pressure-lowering drugs | 187 (24%) | 350 (60%) | 50 (28%) | 254 (66%) | 48 (38%) | 247 (67%) | |
| Antiplatelet drugs | 50 (6%) | 129 (22%) | 17 (9%) | 105 (27%) | 14 (11%) | 90 (24%) | |
| Oral anticoagulant drugs | 21 (3%) | 95 (16%) | 3 (2%) | 69 (18%) | 8 (6%) | 76 (21%) | |
| Glucose-lowering drugs | 77 (10%) | 121 (21%) | 27 (15%) | 104 (27%) | 26 (21%) | 82 (22%) | |
| Antipsychotic drugs and cholinesterase inhibitors | 13 (2%) | 24 (4%) | 7 (4%) | 30 (8%) | 5 (4%) | 64 (17%) | |
| Number of prescribed drugs | 1 (1–4) | 4 (2–7) | 1 (1–5) | 6 (3–9) | 3 (1–6) | 6 (3–9) | |
| Outcome | |||||||
| Hospital mortality | 30 (4%) | 112 (19%) | 10 (6%) | 122 (32%) | 13 (10%) | 169 (46%) | |
| Intensive care unit admission | 187 (24%) | 166 (28%) | 41 (23%) | 63 (16%) | 62 (50%) | 97 (26%) | |
Data are median (IQR) or n (%). CFS=Clinical Frailty Scale.